Related Experiment Video
Updated: Jan 30, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Proton-Activated Artificial Channels for pH-Selective Cancer Therapy
Daoxin Luo1,2, Chunyan Jia1,2, Yuchao Lin1
1Fujian Provincial Key Laboratory of Innovative Drug Target Research, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, China.
Researchers developed novel proton-activated artificial ion channels using self-assembled peptides. These channels show enhanced cancer cell killing in acidic tumor environments, offering a promising platform for targeted cancer therapy.
Area of Science:
- Biomaterials Science
- Chemical Biology
- Nanotechnology
Background:
- Proton-activated ion channels are crucial for cellular adaptation to acidic environments.
- Mimicking these channels artificially presents significant challenges in biomaterial design.
Purpose of the Study:
- To create novel proton-activated artificial ion channels.
- To investigate their potential for selective cancer therapy in acidic tumor microenvironments.
Main Methods:
- Self-assembled peptide chains were integrated into a pH-responsive 2,2'-bipyridine scaffold.
- Protonation-induced conformational changes drove channel formation and small molecule transport.
- Cytotoxicity and selectivity assays were performed on human colorectal carcinoma cells.
Main Results:
- The artificial ion channels demonstrated pH-dependent functionality, with increased cytotoxicity at lower pH.
- The C-FF channel exhibited a 10.3-fold enhancement in cytotoxicity against cancer cells (IC50 of 2.8 µM) via apoptosis and cell cycle arrest.
- Exceptional selectivity for cancer cells (selectivity index of 8.5) was observed, surpassing doxorubicin.
Conclusions:
- A novel class of proton-activated artificial ion channels was successfully developed.
- These channels show potential for targeted anticancer therapy by exploiting acidic tumor microenvironments.
- The platform offers enhanced potency and selectivity compared to existing chemotherapeutics.
More Related Videos
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
12:24Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
Proton (¹H) NMR: Chemical Shift
Absorption signals of all the protium nuclei...